Trial · NCT01354197

The Thai Surgical Intensive Care Study (Thai-SICU Study)

NCT01354197, Completed, Royal College of Anesthesiologists of Thailand; results first posted 2017-03-27

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. The Thai Surgical Intensive Care Study (Thai-SICU Study). Trials, record NCT01354197. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01354197

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: The Thai Surgical Intensive Care Study (Thai-SICU Study)
NCT number: NCT01354197
Status: Completed
Enrollment: 4,652 participants, actual
Lead sponsor: Royal College of Anesthesiologists of Thailand
Conditions: Complications of Surgical and Medical Care: General Terms, Adverse Reaction to Drug, Sequelae of External Causes of Morbidity and Mortality, Critical Illness
First posted: 2011-05-16
Last updated: 2017-03-27
Results first posted: 2017-03-27

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Overall Mortality	28 days	Number of Participants who Did Not Survive up to 28 days after surgical ICU admission
Secondary	Readmission to ICU	3 days	Number of Participants with Readmission to ICU up to 3 days (72 hours) after discharge from ICU

Source ClinicalTrials.gov

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Overall Mortality	28 days		participants	NUMBER
SECONDARY	Readmission to ICU	3 days		participants	NUMBER

Source ClinicalTrials.gov

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Category	Value	Spread	Units
Overall Mortality	All ICU Admission Patients		642		participants
Readmission to ICU	All ICU Admission Patients		144		participants

Source ClinicalTrials.gov

Participant flow3

How many started, completed or left each group, period by period.

Period	Milestone	Group	Participants
Overall Study	STARTED	All ICU Admission Patients	4,652
Overall Study	COMPLETED	All ICU Admission Patients	4,652
Overall Study	NOT COMPLETED	All ICU Admission Patients	0

Source ClinicalTrials.gov

Adverse events36

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

Type	Event	Organ system	Group	Affected	At risk	Events
other	Delirium	Nervous system disorders	Survive at Day 28	117	4,010	117
other	Delirium	Nervous system disorders	Non-survive at Day 28	46	642	46
other	Reintubation within 72 hours	Respiratory, thoracic and mediastinal disorders	Survive at Day 28	112	4,010	112
other	Reintubation within 72 hours	Respiratory, thoracic and mediastinal disorders	Non-survive at Day 28	29	642	29
other	Pneumothorax	Respiratory, thoracic and mediastinal disorders	Survive at Day 28	14	4,010	14
other	Pneumothorax	Respiratory, thoracic and mediastinal disorders	Non-survive at Day 28	11	642	11
other	Unplanned extubation	Respiratory, thoracic and mediastinal disorders	Survive at Day 28	41	4,010	41
other	Unplanned extubation	Respiratory, thoracic and mediastinal disorders	Non-survive at Day 28	16	642	16
other	Self reported medication error	Surgical and medical procedures	Survive at Day 28	7	4,010	7
other	Self reported medication error	Surgical and medical procedures	Non-survive at Day 28	3	642	3

1 to 10 of 36Source ClinicalTrials.gov

See all 36 adverse events

Adverse event totals6

The totals the trial posted for each group.

Total	Group	Affected	At risk
Total, all-cause mortality	Survive at Day 28
Total, all-cause mortality	Non-survive at Day 28
Total, other adverse events	Survive at Day 28	253	4,010
Total, other adverse events	Non-survive at Day 28	90	642
Total, serious adverse events	Survive at Day 28	1,070	4,010
Total, serious adverse events	Non-survive at Day 28	519	642

Source ClinicalTrials.gov

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Survive at Day 28 vs Non-survive at Day 28: serious adverse events

Source Trial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01354197

GET https://conductscience.org/api/trials/v1/NCT01354197/events?page=2

API reference For AI assistants